Today: 10 June 2026
Browse Category

NSE:TENNIND 17 November 2025 - 19 November 2025

Tenneco Clean Air India IPO: GMP Nears ₹123 on 16 November, 60x Subscription Sets Up Big Listing on 19 November

Tenneco Clean Air IPO Allotment Today (Nov 17, 2025): Check Status on MUFG Intime, BSE & NSE — Latest GMP, Listing Date, Lot Size and Subscription Data

Tenneco Clean Air India’s IPO allotment is set to be finalized today, November 17. The ₹3,600 crore offer was subscribed 58.83 times overall, with QIBs at 166.42 times. Shares are scheduled to list November 19 on BSE and NSE. Unofficial grey market premium stands at ₹122–₹125, indicating an implied listing price near ₹520.
17 November 2025
··

Stock Market Today

  • 3 High ROE Stocks With Solid Balance Sheets Highlighted for Investors
    June 10, 2026, 9:01 AM EDT. Investors seeking stability amid inflation and geopolitical tensions may focus on companies with high return on equity (ROE) and robust balance sheets. Regis Resources (ASX:RRL) stands out with a 25.7% ROE, strong revenue from Australian gold projects, and forecasts of earnings growth above 20%. However, it faces risks from gold price fluctuations and project approvals. Aristocrat Leisure (ASX:ALL) features as a global gaming technology leader with substantial revenue streams and solid financial fundamentals. These stocks provide potential resilience against margin pressure and volatile input costs, offering a grounded starting point for quality-focused investment research.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Go toTop